Microphysiological systems to elucidate the gut-brain axis biology of Parkinson’s disease
Parkinson’s disease is the second most common neurodegenerative disease and progressively limits fine motor control. Recent focus has hinted the disease origin could lie at least partially in the gut. Adam’s work focuses on integrating aspects of gut-brain axis physiology into ABNEL’s cut and assemble microfluidic chip designs to contribute to a better scientific understanding of Parkinson’s disease.
Adam joined ABNEL as a Chemical Engineering PhD student in September 2018. Prior, he did research on predicting the mixing of pharmaceutical systems using computational fluid dynamics (CFD). Adam also completed five internships (Johnson & Johnson [twice], Shamrock Technologies, Exxon Mobil, and Merck & Co) mainly in the healthcare/pharmaceutical industry supporting research, engineering, and commercialization.
B.S. Chemical Engineering
New Jersey Institute of Technology (NJIT) ‘18
ABNEL was awarded a patent titled: Fluidic Device and Method of Assembling SAME. https://patents.justia.com/patent/20190083979
Francesco Fontana joined the lab as a visiting scholar over the winter from Italy and conducted experiments in magnetism on cells. He will hopefully defend his thesis in the coming months. Good luck Francesco!